Government keen to push tie-ups between Italian API makers and Indian firms

摘要

The government is looking to attract Italian bulk drug makers for manufacturing tie-ups with Indian pharma firms as it bids to cut dependence on China for pharmaceutical ingredients. India sources over 70% of its requirement of APIs from Chinese pharmaceutical companies. The government, which will unveil a new bulk drug policy soon, is preparing schemes aimed at wooing Italian drug makers with attractive incentives as a part of its 'Make-in-India' initiative.